Elysium Health

New York, NY · Founded 2014 · Privately Held (backing)

Producer of health supplements intended to turn critical scientific advancements into accessible consumer products. Elysium Health is based in New York, NY and was founded in 2014. Its last known valuation is $240 million. It has raised $392 million across 1 recorded round; the latest was a $20 million early-stage round in Oct 2016.

Last price · $/share
—
Implied valuation
$240.0M
Total raised
$391.6M
Last round
Early Stage VC
Oct 2016
How much has Elysium Health raised?
$391.6Macross 1 recorded rounds · Oct 2016 – Oct 2016

Most recently, Elysium Health raised $20.0M in its Early Stage VC (Oct 2016).

Free account
More of Elysium Health with a free account
  • ·The complete investor list: 28 names
  • ·Watch Elysium Health: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Elysium Health round by round

1 rounds
Oct 2016Early Stage VC$20.0MSEC filing▮
6 investors participated

How much has Elysium Health raised?

Elysium Health has raised $392 million in total; 1 of its rounds is on record. The largest on record was a $20 million early-stage round in Oct 2016.

Elysium Health has filed 1 Form D with the SEC, most recently in Dec 2016 ($20 million sold to 6 investors).

Elysium Health investors

28 investors are on record for Elysium Health, including General Catalyst, Gaingels, Calm Ventures and Western Technology Investment. By type, the record holds 11 venture capital firms, 1 family office and 1 growth equity firm. The early-stage round in Oct 2016 drew 6 investors.

For fundraisers
Raising for a company like Elysium Health?

28 investors have backed Elysium Health.

See all 28 investors →

Frequently asked about Elysium Health

How much has Elysium Health raised?
Elysium Health has raised $391.6M in total across 1 recorded funding rounds.
When was Elysium Health's last funding round?
Elysium Health's most recent recorded round was Early Stage VC in Oct 2016, raising $20.0M.